drugset / Trial / NCT00395395

Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal Women

NCT00395395

Phase 1 Completed 56 enrolled Novartis
RandomizedCrossoverDouble-blindTreatment

Summary

This is a phase I study to analyze the effect of water and food intake on the bioavailability and pharmacodynamic of oral salmon calcitonin (SMC021) and salmon calcitonin nasal spray in post-menopausal women.

Timeline

Start
2006-10
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject salmon calcitonin Unknown 0.8 mg Oral